PI11535 Ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate (CAS No.: 64485-82-1)

Ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate (CAS No.: 64485-82-1) Description

Ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate (C7H9N3O3S, CAS 64485-82-1) is a powder pharmaceutical intermediate used in multi-step synthetic routes. Its reactive functional groups allow nucleophilic addition reactions under controlled conditions. The compound is characterised using spectroscopic and chromatographic techniques to determine its purity, which is essential for subsequent chemical transformations in the production of active pharmaceutical ingredients.

Ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate (CAS No.: 64485-82-1) Applications

1.         Pharmaceutical Synthesis
- Used as a key intermediate in drug synthesis to achieve controlled reaction kinetics by utilising its defined reactive profile.
- Applied in process optimisation for active pharmaceutical ingredient production to enhance conversion efficiency with its standardised powder form.

2.         Research and Development
- Employed as a model compound in medicinal chemistry research to study reaction mechanisms, benefiting from its well-characterised chemical structure.
- Utilised in pilot studies for new synthesis pathways to evaluate material behaviour in prototype formulations.

Ethyl 2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetate (CAS No.: 64485-82-1) Packing

The product is packaged in moisture-proof, sealed containers that use inert materials to prevent contamination and degradation. The containers are designed to maintain a stable environment, minimising exposure to humidity and temperature fluctuations. Protective layering and tamper-evident seals further safeguard the powder during transit and storage. Custom packaging options, including specific labelling and compartmentalisation, are available upon request.

Additional Information

Pharmaceutical intermediates play a crucial role in the synthesis of active pharmaceutical ingredients by serving as building blocks that undergo further chemical transformations. Their stringent characterisation is necessary to ensure that downstream processes yield compounds with precise chemical properties. This careful evaluation supports reproducibility in scale-up production.

Advanced manufacturing practices, such as those employed by Stanford Advanced Materials, focus on controlled synthesis environments and standardised quality assessments. Understanding the chemical reactivity and stability of intermediates assists in designing efficient synthesis pathways and addresses challenges in scalability and formulation consistency.